Live feed
Filing
SCHEDULE 13D/A
SCHEDULE 13D/A0001857948-26-000003·Mallick Parag
Schedule 13D ownership disclosure
Nautilus Biotechnology, Inc.
Common stock, par value $0.0001 per share · CUSIP: 63909J108
Event date: 2026-03-02
- Filing-level shares
- 22,557,411.00
- Percent of class
- 17.6%
- Parag MallickReported CIK 0001857948
Shares: 22,557,411.00 · Class: 17.6%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001857948-26-000003
- Form type
- SCHEDULE 13D/A
- Filer
- Mallick Parag
- CIK
- CIK 1857948
- Filed
- Mar 04, 2026
- Reporting period
- Mar 02, 2026
- Description
- Schedule 13D beneficial ownership